Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines.
Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST) IDRX-42 offers potential to address all key KIT...
DREAMM-7 trial shows sustained overall survival benefit for belantamab mafodotin combination versus daratumumab combination; benefit seen early and maintained through follow-up Data build on...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.1 | 3.23434284034 | 34.01 | 35.585 | 33.95 | 5036667 | 35.14080561 | DR |
| 4 | 1.18 | 3.47774830533 | 33.93 | 35.585 | 31.715 | 4255187 | 33.8874707 | DR |
| 12 | -0.99 | -2.74238227147 | 36.1 | 36.74 | 31.715 | 4719918 | 34.19883716 | DR |
| 26 | -4.14 | -10.5477707006 | 39.25 | 44.67 | 31.715 | 4784910 | 37.3728419 | DR |
| 52 | -5.52 | -13.5860201821 | 40.63 | 45.925 | 31.715 | 4171177 | 39.17142051 | DR |
| 156 | -9.67 | -21.5944618133 | 44.78 | 46.97 | 28.465 | 4437744 | 37.89976392 | DR |
| 260 | -12.1 | -25.630163101 | 47.21 | 48.19 | 28.465 | 4431309 | 38.37311946 | DR |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
